David E. Harbourt
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Modeling and Simulation top 10%
- COVID-19 epidemiological studies
Papers in
-
- Viral gastroenteritis research and epidemiology 2
- Infection Control in Healthcare 2
- Viral Infections and Vectors 2
-
- Carcinogens and Genotoxicity Assessment 1
- Co-authors
- John K. Fallon (2 shared papers)Philip Coleridge Smith (2 shared papers)Joseph K. Ritter (2 shared papers)Gary L. Glish (1 shared paper)Shinya Ito (1 shared paper)Takashi Baba (1 shared paper)Andrew D. Haddow (3 shared papers)Holly A. Bloomfield (3 shared papers)
- Journals
- American Journal of Tropical Medicine and Hygiene (2 papers)Analytical Chemistry (1 paper)Emerging infectious diseases (1 paper)The Journal of Infectious Diseases (1 paper)PLoS neglected tropical diseases (1 paper)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
David E. Harbourt
11 papers receiving 395 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 136
- Modeling and Simulation 31
- Infectious Diseases 81
- General Dentistry 6
- Oncology 94
Countries citing papers authored by David E. Harbourt
This map shows the geographic impact of David E. Harbourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Harbourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Harbourt more than expected).
Fields of papers citing papers by David E. Harbourt
This network shows the impact of papers produced by David E. Harbourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Harbourt. The network helps show where David E. Harbourt may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Harbourt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 157 | |
| 2 | 2020 | 110 | |
| 3 | 2010 | 47 | |
| 4 | 2008 | 42 | |
| 5 | 2019 | 16 | |
| 6 | 2020 | 9 | |
| 7 | 2020 | 9 | |
| 8 | 2020 | 4 | |
| 9 | 2017 | 4 | |
| 10 | 2016 | 3 | |
| 11 | 2019 | 1 |
About David E. Harbourt
David E. Harbourt is a scholar working on Infectious Diseases, Cancer Research, Pulmonary and Respiratory Medicine, Transplantation and Microbiology, having authored 11 papers that have together received 402 indexed citations. Recurring topics across this work include Infection Control and Ventilation (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Viral gastroenteritis research and epidemiology (2 papers), Infection Control in Healthcare (2 papers), Viral Infections and Vectors (2 papers), Pancreatic function and diabetes (1 paper), Carcinogens and Genotoxicity Assessment (1 paper) and Renal Transplantation Outcomes and Treatments (1 paper). The work is most often cited by research in Pharmacology (136 citations), Modeling and Simulation (31 citations), Infectious Diseases (81 citations), General Dentistry (6 citations) and Oncology (94 citations). David E. Harbourt has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include John K. Fallon, Philip Coleridge Smith, Joseph K. Ritter, Gary L. Glish, Shinya Ito, Takashi Baba, Andrew D. Haddow, Holly A. Bloomfield, Brian J. Kearney and David P. Fetterer. Their work appears in journals such as American Journal of Tropical Medicine and Hygiene, Analytical Chemistry, Emerging infectious diseases, The Journal of Infectious Diseases and PLoS neglected tropical diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.